A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Cotton, Colleagues Urge Administration to Change Israeli Goods Labeling Policy
Washington, D.C. — U.S. Senators Marco Rubio (R-FL), Tom Cotton (R-AR), Ted Cruz (R-TX), and Kelly Loeffler (R-GA) sent a letter to President Donald Trump urging the Administration to change U.S. customs policy and guidelines to allow Israeli goods produced in Judea and Samaria to be labeled “Made in Israel.”
“Your administration should continue its string of pro-Israel policy changes by undoing these misguided Clinton-era guidelines, thereby allowing Israeli goods produced in Judea and Samaria to be labeled as ‘Made in Israel’,” the senators wrote. “This decision would be yet another achievement by your administration that would support Israel and would push back against anti-Semitism and the BDS movement.”
The full text of the letter is below.
Mr. President,
We write to urge you to change U.S. customs policy and guidelines to allow Israeli goods produced in Judea and Samaria to be labeled “Made in Israel.”
We appreciate your leadership and many achievements in support of Israel, our closest ally in the Middle East. Unfortunately, the United Nations and some prominent members of the Democratic Party are working to oppose Israel and to support the anti-Semitic Boycott, Divestment, and Sanctions (BDS) movement, which seeks to isolate and damage Israel economically. In order to provide the BDS movement with targets for its anti-Israel boycotts, the UN High Commissioner for Human Rights released on February 12, 2020 a blacklist of over 100 Israeli, U.S., and other international companies operating in Judea and Samaria.
In 2016, the Obama administration republished country-of-origin labeling guidelines introduced by the Clinton administration in 1995. These Clinton-era guidelines changed longstanding U.S. policy to require “Made in West Bank ” labels to be put on Israeli goods produced in Judea and Samaria, even though the U.S. government treats these products as “articles of Israel” for trade purposes. While it is our understanding that this labeling policy is not enforced by U.S. authorities, we are concerned that a future administration could choose to enforce these rules and thereby differentiate Israeli goods produced in Judea and Samaria, making them prime targets for BDS boycotts.
Your administration should continue its string of pro-Israel policy changes by undoing these misguided Clinton-era guidelines, thereby allowing Israeli goods produced in Judea and Samaria to be labeled as “Made in Israel.” This decision would be yet another achievement by your administration that would support Israel and would push back against anti-Semitism and the BDS movement.
Thank you for considering this important matter. We look forward to hearing from you.